HomeCompareEW vs GPN

EW vs GPN: Dividend Comparison 2026

EW yields 2.52% · GPN yields 1.51%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 GPN wins by $7.0K in total portfolio value· pulled ahead in Year 4
10 years
EW
EW
● Live price
2.52%
Share price
$79.50
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$23.4K
Annual income
$295.93
Full EW calculator →
GPN
GPN
● Live price
1.51%
Share price
$66.30
Annual div
$1.00
5Y div CAGR
27.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.5K
Annual income
$2,458.46
Full GPN calculator →

Portfolio growth — EW vs GPN

📍 GPN pulled ahead of the other in Year 4

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodEWGPN
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, EW + GPN cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
EW pays
GPN pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EW
Annual income on $10K today (after 15% tax)
$213.84/yr
After 10yr DRIP, annual income (after tax)
$251.54/yr
GPN
Annual income on $10K today (after 15% tax)
$128.21/yr
After 10yr DRIP, annual income (after tax)
$2,089.69/yr
At 15% tax rate, GPN beats the other by $1,838.15/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EW + GPN for your $10,000?

EW: 50%GPN: 50%
100% GPN50/50100% EW
Portfolio after 10yr
$27.0K
Annual income
$1,377.19/yr
Blended yield
5.11%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on GPN right now

EW
Analyst Ratings
32
Buy
16
Hold
Consensus: Buy
Price Target
$96.38
+21.2% upside vs current
Range: $87.00 — $110.00
Altman Z
10.9
Piotroski
5/9
GPN
Analyst Ratings
37
Buy
21
Hold
4
Sell
Consensus: Buy
Price Target
$94.25
+42.2% upside vs current
Range: $80.00 — $109.00
Altman Z
0.9
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EW buys
0
GPN buys
0
No recent congressional trades found for EW or GPN in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricEWGPN
Forward yield2.52%1.51%
Annual dividend / share$2.00$1.00
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%27.6%
Portfolio after 10y$23.4K$30.5K
Annual income after 10y$295.93$2,458.46
Total dividends collected$2.8K$9.1K
Payment frequencyquarterlyquarterly
SectorHealthcareStock
Analyst consensusBuyBuy
Analyst price target$96.38$94.25

Year-by-year: EW vs GPN ($10,000, DRIP)

YearEW PortfolioEW Income/yrGPN PortfolioGPN Income/yrGap
1$10,952$251.57$10,892$192.46+$60.00EW
2$11,976$257.49$11,905$249.99+$71.00EW
3$13,077$263.14$13,064$325.83+$13.00EW
4← crossover$14,261$268.55$14,405$426.40$144.00GPN
5$15,533$273.70$15,974$560.68$441.00GPN
6$16,899$278.61$17,834$741.46$935.00GPN
7$18,365$283.28$20,069$987.14$1.7KGPN
8$19,938$287.72$22,799$1,324.75$2.9KGPN
9$21,626$291.93$26,189$1,794.67$4.6KGPN
10$23,436$295.93$30,481$2,458.46$7.0KGPN

EW vs GPN: Complete Analysis 2026

EWHealthcare

Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides the PASCAL and Cardioband transcatheter valve repair systems for minimally-invasive therapy. In addition, it offers surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; KONECT RESILIA, a pre-assembled aortic tissue valved conduit for patients who require replacement of the valve, root, and ascending aorta; and HARPOON Beating Heart Mitral Valve Repair System for patients with degenerative mitral regurgitation. Further, the company provides critical care solutions, including advanced hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

Full EW Calculator →

GPNStock

Global Payments Inc. provides payment technology and software solutions for card, electronic, check, and digital-based payments in the Americas, Europe, and the Asia-Pacific. It operates through three segments: Merchant Solutions, Issuer Solutions, and Business and Consumer Solutions. The Merchant Solutions segment offers authorization services, settlement and funding services, customer support and help-desk functions, chargeback resolution, terminal rental, sales and deployment, payment security services, consolidated billing and statements, and on-line reporting services. This segment also provides an array of enterprise software solutions that streamline business operations of its customers in various vertical markets; and value-added services, such as point-of-sale solutions, and analytic and engagement tools, as well as payroll and human capital management services. The Issuer Solutions segment offers solutions that enable financial institutions and retailers to manage their card portfolios through a platform; and commercial payments and ePayables solutions for businesses and governments. The Business and Consumer Solutions segment provides general-purpose reloadable prepaid debit and payroll cards, demand deposit accounts, and other financial service solutions to the underbanked and other consumers, and businesses under the Netspend brand. It markets its products and services through direct sales force, trade associations, agent and enterprise software providers, referral arrangements with value-added resellers, and independent sales organizations. The company was founded in 1967 and is headquartered in Atlanta, Georgia.

Full GPN Calculator →
📬

Get this EW vs GPN comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EW vs SCHDEW vs JEPIEW vs OEW vs KOEW vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.